1331 / 1816
Neoadjuvant chemotherapy
Many new questions for radiation oncology/locoregional treatment
The risk of LRR according to pathological extent of disease after
neoadjuvant chemotherapy is different than the risk in patients
treated with initial surgery
Lack of pathologic stage to guide indications
•
Treatment response and indications
–
Breast conservation
–
Postmastectomy radiation
–
Regional lymph node radiation
•
Are new strategies for poor responders needed?
Clinical studies on locoregional treatment after NAC by L. Boersma